How do proteins efficiently and precisely shift from one conformation to another? Gardino et al. (2009) show that transient hydrogen bonds are critical to the conformational transition of the nitrogen regulatory protein NtrC between its native state and its active state.
Nearly all cancer cells contain abnormal chromosomes. Of particular importance are chromosomal translocations that form when chromosomes suffer breaks but are not properly repaired and then illegitimately fuse to each other. Although translocations are sometimes secondary events in tumors, translocated chromosomes can be causal in some cancers. Despite their prevalence and importance, little is known about how cancer translocations form in an intact cell. In this issue of Cell, Lin et al. (2009) outline several molecular events leading to chromosome translocations. What they find suggests a prominent role for chromatin structure in predisposing genome regions for breakage, and their results may provide an explanation for the wellknown cell-type specificity of some chromosomal translocations. Lin et al. use prostate cancer as a model to study translocation mechanisms (Lin et al., 2009 ). This is a useful system, as an estimated 50%-70% of prostate tumors contain translocations between the TMPRSS2 gene on chromosome 21 and the ERG or ETV1 loci on chromosomes 21 and 7, respectively (Tomlins et al., 2005) . TMPRSS2 is a target gene of male androgen hormones, which play a critical role in prostate development and tumor formation. Lin et al. first asked whether androgens play any role in the formation of translocations in prostate cancer cells that lacked these gene fusions. Remarkably, they found that after induction of genotoxic stress by irradiation far more translocations formed in prostate cancer cells when androgens were present than when they were absent (Lin et al., 2009) . Their ensuing quest to unravel how androgens promote the formation of translocations has lead to the discovery of several new potential translocation mechanisms.
The key to how androgens promote translocation frequency lies in the fact that the translocation regions, TMPRSS2, ERG, and ETV, all contain binding sites for the androgen receptor (AR) near their breakpoints. Lin et al. show that after treatment of prostate cancer cells with androgens, there is rapid recruitment of AR to these sites. This has several severe consequences. To start with, AR is known to be a strong transcriptional activator, and, not surprisingly, its recruitment induces changes in higher-order chromatin structure and epigenetic modifications indicative of open, active chromatin (Figure 1 ). This may make these sites more susceptible to breakage. AR binding also induces changes in the physical location of genomic regions within the nucleus, bringing them into close spatial proximity and thus predisposing them for their eventual fusion (Figure 1) . However, the most fateful consequence of AR binding is the recruitment of cellular machinery that can cause DNA double-strand breaks when the cells are exposed to genotoxic stress. In particular, AR attracts the activation-induced cytidine deaminase (AID) via its cofactor, Gadd45, to chromatin. AID is a key factor in somatic hypermutation (SHM) and class-switch recombination (CSR) in B lymphoid cells, where it contributes to DNA breakage during the process of generating antibody diversity ( Figure 1 ).
These results tell us that transcription factor binding and higher-order chromatin structure play a key role in determining the chromosomal sites of translocation breakpoints. These observations in prostate cells echo recent observations on the contribution of transcription and chromatin structure in the formation of translocations. Analysis of translocation mechanisms in anaplastic large-cell lymphoma, which is characterized by a t(2;5) translocation, revealed that several genes in the vicinity of the translocation breakpoints are transcriptionally active before translocations occur (Mathas et al., 2009 ). Similar to the situation in prostate cancer, it was hypothesized that the aberrant expression of these genes was caused by inappropriate binding of transcription factors or by changes to higher-order chromatin structure.
The findings by Lin et al. also strengthen the notion that translocations preferentially occur between proximally positioned chromosomes (Misteli and Soutoglou, 2009) . Correlations between spatial proximity and translocation frequency are now widespread and have been demonstrated for many tumor translocations, including MYC-IGH in Burkitt's lymphoma and BCR-ABL in chronic myeloid leukemia (Misteli and Soutoglou, 2009 ). Similar to the situation for TMPRSS2:ETV1, in anaplastic large-cell lymphoma, the translocating genome regions on chromosomes 2 and 5 undergo repositioning prior to translocation, moving them into proximity (Mathas et al., 2009 ). This juxtaposition contributes to the increased likelihood of translocation, as demonstrated by the fact that both the anaplastic largecell lymphoma and prostate translocations readily form upon irradiation of cells under conditions in which these genomic regions are in proximity (Lin et al., 2009; Mani et al., 2009; Mathas et al., 2009 Transcription is obviously essential, but even a good thing can be dangerous at times. In this issue, Lin et al. (2009) provide evidence that binding of the transcription machinery may predispose genome regions to breakage and translocations that may lead to cancer.
binding of transcription factors, are a far upstream event in the formation of translocations (Figure 1 ). The observations by Lin et al. also expand the spectrum of functions for AID and support its proposed role in tumor formation. AID has a well-established, important function in B lymphoid cells, where it is critical in the introduction of double-strand breaks in the immunoglobulin genes during SHM and CSR. That AID activity also contributes to translocation formation has been suggested previously, based on the finding that AID is required for the formation of DNA breaks in c-MYC prior to the formation of MYC-IGH translocations in Burkitt's lymphoma (Robbiani et al., 2008) . Although such "off-target" AID activity is well defined in B cells, Lin et al. demonstrate that AID also has deleterious effects in non-B cell types and that neither its expression nor its activity is restricted to B cells (Lin et al., 2009 ). The finding that AID is a critical factor in the formation of prostate cell translocations now raises the possibility that AID is a general translocation factor and may be a key player in the formation of many translocations, including those in solid tumors.
But AR and AID are not the full story. Lin et al. also find a contribution to the translocation frequency by the ORF2 endonuclease encoded by the LINE-1 retroelement (Lin et al., 2009) . ORF2, which is present at higher levels in prostate cancer cells than in normal cells, was selectively recruited to the translocation regions in an androgen-dependent fashion. However, the effect of ORF2 seems to establish an independent translocation pathway, since it was not dependent on AID and ORF2 does not interact with AR (Figure 1 ). It will be of interest to determine why and how ORF2 activity is elevated in transformed cells and what determines ORF2 recruitment.
These observations point to a model in which translocations are a downstream event of transcription factor binding and chromatin remodeling. The parallels between prostate cancer and anaplastic large cell lymphoma are striking, and the fact that similar mechanisms are at play in both solid tumors and lymphoma suggest that this will be a universal mechanism. The Translocations occur by breakage and illegitimate joining of distinct genomic regions (shown in orange and green) either within the same chromosome or on separate chromosomes. Multiple pathways contribute to the formation of translocations. In one pathway, androgen receptor (AR) binds to its target sites in the genome upon stimulation by androgen. Binding of AR induces local chromatin remodeling and leads to spatial association of multiple AR target sites, possibly making these regions susceptible to breakage. Upon genotoxic stress such as irradiation, AR recruits the activation-induced cytidine deaminase AID, which is capable of inducing DNA double-strand breaks. In a second pathway, ORF2, which is overexpressed in cancer cells, associates with target sites in the genome in response to androgen signaling and induces double-strand breaks. Determinants of ORF2 expression and targeting are unknown. Juxtaposed chromosomes containing persistent double-strand breaks induced by either mechanism are prone to translocation. Such translocations may contribute to tumorigenesis. results reveal several novel aspects of translocation mechanisms, but also raise many questions. Why do translocations occur only between TMPRSS2 and its particular translocation partners, when AR binds to many genomic sites? Perhaps other translocations do occur but are lost because they do not provide a growth or survival advantage. Alternatively, the epigenetic makeup of the breakpoint regions, their spatial arrangement, or the involvement of AR cofactors or noncoding RNAs may underlie recurrent translocations. It will be important to characterize the nature of chromatin structure and epigenetic modifications at the breakpoints and to determine how these features influence the recruitment of AR and AID. Also, is AID frequently expressed in prostate carcinoma tissues, and, if so, does it correlate with disease malignancy?
Maybe the most important conceptual implication of the reported findings is the challenge to how we think about translocations. Generally, we have assumed that translocations occur more or less randomly in the genome by stochastic DNA double-strand breaks. The enrichment of particular translocations was then thought to be purely the consequence of a selection process in which only certain subpopulations of cells survive as the randomly generated translocation affords them a growth advantage. This idea needs rethinking. The recent results on blood and solid tumors suggest instead that breaks in the genome occur in a nonrandom fashion and that their sites are determined by where transcription factors bind. It then seems that in addition to selection on the basis of growth properties, recurrent translocations in a tumor may also be a reflection of transcription factor binding patterns and the higher-order chromatin structure landscape. As transcription factor binding and epigenetic patterns are often cell-type specific, they may be a plausible explanation for the cell lineage-and tumor type-specific occurrence of some cancer translocations. An interesting possibility is that we can begin thinking about superimposing currently available transcription factor binding and epigenetic maps with the locations of breakpoints in a wide array of cancers and in this way identify the molecular triggers of specific cancer translocations. If successful, then we have truly entered a new era in understanding cancer and its translocations.
Unlike the static protein structures that grace journal pages, real proteins in solution are dynamic. The internal motions of a protein can be depicted schematically in terms of a free-energy landscape-a terrain map describing protein conformational space (Dill and Chan, 1997; Frauenfelder et al., 1991) . Different conformations (the "valleys") are separated by freeenergy barriers (the "hills"): the difference between the free energies of individual conformations determines their relative abundance, whereas the size and nature of the energy barriers determine the kinetics of conformational exchange (Figure 1 
